Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00926926 · ClinicalTrials.gov registry record · Phase 1
Effects of Oxybutynin Topical Gel on Gastric Emptying
A Phase 1 study, sponsored by Watson Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT00926926 is a Phase 1 study that has completed, run by Watson Pharmaceuticals. The registered enrollment target is 23 participants.
The verdict
NCT00926926, a Phase 1 study, has completed, sponsored by Watson Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study explores the effect of oxybutynin topical gel on gastric emptying
Interventions
- DRUG Placebo Gel
- DRUG Oxybutynin Chloride Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2009-06 |
| Est. Completion | 2009-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00926926
The ClinicalTrials.gov registry entry for NCT00926926 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Watson Pharmaceuticals, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Gel is the first listed.
NCT00926926 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00926926 about?
NCT00926926 is a clinical study titled "Effects of Oxybutynin Topical Gel on Gastric Emptying". This study explores the effect of oxybutynin topical gel on gastric emptying
What is the current status of trial NCT00926926?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2009-06. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00926926?
The interventions under investigation include: Placebo Gel (DRUG), Oxybutynin Chloride Gel (DRUG).
Who is sponsoring clinical trial NCT00926926?
This trial is sponsored by Watson Pharmaceuticals, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.